Tulane University: Study Finds Why Immunotherapies Don't Work On Hardest-To-Treat Breast Cancers
December 16, 2022
December 16, 2022
NEW ORLEANS, Louisiana, Dec. 16 (TNSjou) -- Tulane University issued the following news release:
Thanks to advances in cancer therapies, most forms of breast cancer are highly treatable, especially when caught early.
But the last frontier cases -- those that can't be treated with hormone or targeted therapies and don't respond to chemotherapy -- remain the deadliest and hardest to treat. Tulane University researchers have discovered for the first time how thes . . .
Thanks to advances in cancer therapies, most forms of breast cancer are highly treatable, especially when caught early.
But the last frontier cases -- those that can't be treated with hormone or targeted therapies and don't respond to chemotherapy -- remain the deadliest and hardest to treat. Tulane University researchers have discovered for the first time how thes . . .